Drug Profile
Anti-idiotype cancer vaccine - Viventia Biotech
Alternative Names: 4B5; Monoclonal antibody 4B5; NOVOVAC-M1Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Viventia Biotech
- Class Cancer vaccines; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malignant melanoma